Showing results (11-20 of 121) with videos related to
Sort By:
Pageof 13
Journal of Microbiological Methods|September 10, 2016
Production and evaluation of cytotoxic effects of DT386-BR2 fusion protein as a novel anti-cancer agentFatemeh Shafiee, Mohammad Rabbani, Ali Jahanian-NajafabadiAdvanced Biomedical Research|March 29, 2017
Optimization of the Expression of DT386-BR2 Fusion Protein in <i>Escherichia coli</i> using Response Surface MethodologyFatemeh Shafiee, Mohammad Rabbani, Ali Jahanian-NajafabadiIranian Journal of Pharmaceutical Research : IJPR|March 8, 2021
Optimization of Buffer Additives for Efficient Recovery of hGM-CSF from Inclusion Bodies Using Response Surface MethodologyMina Ahmadian, Ali Jahanian-Najafabadi, Vajihe AkbariResearch in Pharmaceutical Sciences|October 22, 2020
Evaluation of soluble expression of recombinant granulocyte macrophage stimulating factor (rGM-CSF) by three different <i>E. coli</i> strainsSina Soheili, Ali Jahanian-Najafabadi, Vajihe AkbariMolecular Biology Reports|April 1, 2020
Expression and one step intein-mediated purification of biologically active human G-CSF in Escherichia coliSetareh Sima, Fatemeh Shafiee, Ali Jahanian-NajafabadiBiological Trace Element Research|August 16, 2018
Chronic Oral Arsenic Exposure and Its Correlation with Serum S100B ConcentrationJafar Golmohammadi, Ali Jahanian-Najafabadi, Mehdi AliomraniClinical Medicine Insights. Blood Disorders|November 5, 2016
Artificial Blood Substitutes: First Steps on the Long Route to Clinical UtilitySamira Moradi, Ali Jahanian-Najafabadi, Mehryar Habibi RoudkenarJournal of Liposome Research|January 23, 2019
PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2Jaleh Varshosaz, Fatemeh Raghami, Mahboubeh Rostami, et al.CNS & Neurological Disorders Drug Targets|July 14, 2018
Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and ChallengesTahereh Sadeghian-Rizi, Hossein Khanahmad, Ali Jahanian-NajafabadiIranian Journal of Pharmaceutical Research : IJPR|September 19, 2019
A Bi-Functional Targeted P28-NRC Chimeric Protein with Enhanced Cytotoxic Effects on Breast Cancer Cell LinesMeysam Soleimani, Hamid Mirmohammmad Sadeghi, Ali Jahanian-NajafabadiPageof 13